2U3:FRA
Alcon AG
57,08 €
arrow_upward
+0,78%(+0,44) 1D
2. lis, 22:00:00 GMT+2 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 2U3...
Otvori
56,86 €
Najviša
57,08 €
Najniža
56,86 €
Trž. kap.
26,25 mlr.
Prosj. kol.
213,00
Količina
30,00
52-tjed. najviša
73,96 €
52-tjed. najniža
51,78 €
Broj djelatnika
25 tis.
Otvori
56,86 €
Najviša
57,08 €
Najniža
56,86 €
Trž. kap.
26,25 mlr.
Prosj. kol.
213,00
Količina
30,00
52-tjed. najviša
73,96 €
52-tjed. najniža
51,78 €
Broj djelatnika
25 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
AD HOC NEWS
·
prije 16 sati
Jefferies cuts target for Alcon stock from USD 95.00 to USD 85.00
AD HOC NEWS
·
prije 2 dana
Alcon stock after-hours at EUR 57.24: minus 0.68 percent versus prior close
AD HOC NEWS
·
prije 2 dana
Alcon stock launches Systane PRO PF in Canada
Simply Wall St
·
prije 3 dana
Did Dry Eye Drop Launch Just Shift Alcon's (SWX:ALC) Investment Narrative?
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG – informacije
Glavni izvršni direktorDavid J. Endicott
Zaposlenici25 tis.
Osnovano1945
SjedišteŽeneva, Ženeva, Švicarska
Sektor-
Web-lokacijaalcon.com